Diamminodichloroplatinum in the chemotherapy of testicular tumors.
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002822:Choriocarcinoma / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D004407:Dysgerminoma / Q000188:drug therapy*; D006562:Herpes Zoster / Q000150:complications; D006801:Humans; D007668:Kidney / Q000187:drug effects; D008113:Liver Neoplasms; D008175:Lung Neoplasms / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011859:Radiography; D011877:Radionuclide Imaging; D012075:Remission, Spontaneous; D013724:Teratoma / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors; D014012:Tinnitus / Q000139:chemically induced
D000970:Antineoplastic Agents; D002945:Cisplatin